Clinical Trials Logo

Clinical Trial Summary

The purpose of this phase II study is to determine the survival free disease of patients diagnosed with invasive locally advanced carcinomas of uterine cervix treated with induction chemotherapy with cisplatin and gemcitabine followed by chemoradiation and definitive chemoradiation.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01973101
Study type Interventional
Source Instituto do Cancer do Estado de São Paulo
Contact Maria Del Pilar Estevez Diz, MD
Phone 55 11 3893-2000
Email pesquisa.clinica@icesp.org.br
Status Recruiting
Phase Phase 2
Start date June 2012
Completion date April 2017